I agree that this site is using cookies. You can find further informations here.
X
Goll, Guro L
116  results:
Search for persons X
?
1

Therapeutic Drug Monitoring: A Tool to Optimize Treatment o..:

Syversen, Silje W. ; Gehin, Johanna E. ; Goll, Guro L....
Arthritis & Rheumatology.  76 (2024)  5 - p. 667-669 , 2024
Link: https://doi.org/10.1002/..
 
?
2

Biosimilar tocilizumab—better access and lower cost?:

Goll, Guro L ; Kvien, Tore K
The Lancet Rheumatology.  6 (2024)  1 - p. e6-e8 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Improving patient access to biosimilar tumor necrosis facto..:

Goll, Guro L ; Kvien, Tore K
Expert Opinion on Biological Therapy.  23 (2023)  12 - p. 1203-1209 , 2023
Link: https://doi.org/10.1080/..
 
?
4

Cytokine Patterns as Predictors of Antibiotic Treatment Eff..:

Bråten, Lars Christian Haugli ; Gjefsen, Elisabeth ; Gervin, Kristina...
Journal of Pain Research.  16 (2023)  - p. 1713-1724 , 2023
Link: https://doi.org/10.2147/..
 
?
5

101: GENETIC PREDISPOSITION TO INFLIXIMAB IMMUNOGENICITY IN..:

Bj⊘rlykke, Kristin H. ; Brun, Marthe K. ; Viken, Marte K....
Gastroenterology.  162 (2022)  7 - p. S-17-S-18 , 2022
Link: https://doi.org/10.1016/..
 
?
6

Immune response and safety in standard and third dose SARS-..:

Jorgensen, Kristin ; Chopra, Adity ; Sexton, Joseph...
Journal of Hepatology.  77 (2022)  - p. S309-S310 , 2022
Link: https://doi.org/10.1016/..
 
?
7

Immunogenicity and Safety of Standard and Third‐Dose SARS–C..:

Syversen, Silje W. ; Jyssum, Ingrid ; Tveter, Anne T....
Arthritis & Rheumatology.  74 (2022)  8 - p. 1321-1332 , 2022
Link: https://doi.org/10.1002/..
 
?
8

Sa1052: IMMUNOGENICITY AND SAFETY OF STANDARD AND THIRD DOS..:

Joergensen, Kristin K. ; Syversen, Silje W ; Jyssum, ingrid...
Gastroenterology.  162 (2022)  7 - p. S-287 , 2022
Link: https://doi.org/10.1016/..
 
?
9

Identification of SNPs associated with methotrexate treatme..:

Kolan, Shrikant S. ; Li, Gaoyang ; Grimolizzi, Franco...
Frontiers in Pharmacology.  13 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
10

231: PROACTIVE THERAPEUTIC DRUG MONITORING IS SUPERIOR TO S..:

Joergensen, Kristin K. ; Syversen, Silje W ; Goll, Guro L....
Gastroenterology.  162 (2022)  7 - p. S-44-S-45 , 2022
Link: https://doi.org/10.1016/..
 
?
11

Macrophage migration inhibitory factor: a potential biomark..:

Gjefsen, Elisabeth ; Gervin, Kristina ; Goll, Guro...
RMD Open.  7 (2021)  2 - p. e001726 , 2021
Link: https://doi.org/10.1136/..
 
?
12

Rheumatoid factor and falsely elevated results in commercia..:

Gehin, Johanna E. ; Klaasen, Rolf A. ; Norli, Ellen S....
Rheumatology International.  41 (2021)  9 - p. 1657-1665 , 2021
Link: https://doi.org/10.1007/..
 
?
13

An Opportunity Missed: Biosimilars in the United States:

Goll, Guro L. ; Kvien, Tore K.
Arthritis & Rheumatology.  72 (2020)  7 - p. 1046-1048 , 2020
Link: https://doi.org/10.1002/..
 
?
14

Efficacy and Safety of CT-P13 in Inflammatory Bowel Disease..:

Jørgensen, Kristin K. ; Goll, Guro L. ; Sexton, Joe...
BioDrugs.  34 (2020)  5 - p. 681-694 , 2020
Link: https://doi.org/10.1007/..
 
?
15

Therapeutic drug monitoring of infliximab compared to stand..:

Syversen, Silje W ; Goll, Guro L ; Jørgensen, Kristin K...
Trials.  21 (2020)  1 - p. , 2020
Link: https://doi.org/10.1186/..
 
1-15